FibroGen Inc [NASDAQ: FGEN] stock went on an upward path that rose over 18.10% on Tuesday, amounting to a one-week price increase of more than 22.32%.
Over the last 12 months, FGEN stock dropped by -92.13%. The one-year FibroGen Inc stock forecast points to a potential upside of 8.67. The average equity rating for FGEN stock is currently 4.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $136.27 million, with 98.77 million shares outstanding and 92.45 million shares in the current float. Compared to the average trading volume of 1.89M shares, FGEN stock reached a trading volume of 34021147 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on FibroGen Inc [FGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FGEN shares is $1.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FGEN stock is a recommendation set at 4.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for FibroGen Inc shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on August 08, 2023. The new note on the price target was released on June 26, 2023, representing the official price target for FibroGen Inc stock.
The Average True Range (ATR) for FibroGen Inc is set at 0.20, with the Price to Sales ratio for FGEN stock in the period of the last 12 months amounting to 0.81.
FGEN Stock Performance Analysis:
FibroGen Inc [FGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.32. With this latest performance, FGEN shares dropped by -15.95% in over the last four-week period, additionally plugging by 111.62% over the last 6 months – not to mention a drop of -92.13% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FGEN stock in for the last two-week period is set at 50.88, with the RSI for the last a single of trading hit 62.09, and the three-weeks RSI is set at 47.66 for FibroGen Inc [FGEN]. The present Moving Average for the last 50 days of trading for this stock 1.6950, while it was recorded at 1.1940 for the last single week of trading, and 1.2082 for the last 200 days.
Insight into FibroGen Inc Fundamentals:
FibroGen Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.27 and a Current Ratio set at 1.41.
FibroGen Inc [FGEN] Institutonal Ownership Details
The top three institutional holders of FGEN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in FGEN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in FGEN stock with ownership which is approximately 5.8386%.
